Adimab, LLC
- Biotech or pharma, therapeutic R&D
- CMO, CRO
Adimab is currently the industry's leading antibody and bispecifics discovery and protein engineering company based on unrivaled quality and speed from target to therapeutic molecule. Adimab has over 135 partners that have generated over 600 therapeutic programs to date.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}